Cargando…

The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis

High doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) have been well-documented to reduce the expression of serotonergic markers in several forebrain regions of rats and nonhuman primates. Neuroimaging studies further suggest that at least one of these markers, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biezonski, Dominik K, Meyer, Jerrold S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137208/ https://www.ncbi.nlm.nih.gov/pubmed/21886568 http://dx.doi.org/10.2174/157015911795017146

Ejemplares similares

3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013)

Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation
por: Puerta, Elena, et al.
Publicado: (2011)

Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022)

MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology
por: Sáez-Briones, P., et al.
Publicado: (2013)

Methylenedioxymethamphetamine (MDMA)-Induced Hyponatremia: Case Report and Literature Review
por: Elkattawy, Sherif, et al.
Publicado: (2021)

Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
por: Wunderli, Michael D, et al.
Publicado: (2017)

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review
por: Inouye, Ann, et al.
Publicado: (2022)

Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing
por: Agurto, Carla, et al.
Publicado: (2020)

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
por: Baumann, Michael H., et al.
Publicado: (2006)

The influence of the host microbiome on 3,4-methylenedioxymethamphetamine (MDMA)-induced hyperthermia and vice versa
por: Ridge, Emily A., et al.
Publicado: (2019)

Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy)
por: Movassaghi, Shabnam, et al.
Publicado: (2013)

Effects of Repeated Administration of 3,4-methylenedioxymethamphetamine (MDMA) on Avoidance Memory and Cell Density in Rats’ Hippocampus
por: Jahanshahi, Mehrdad, et al.
Publicado: (2013)

Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
por: Kamboj, Sunjeev K., et al.
Publicado: (2017)

Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations
por: Neumann, Joachim, et al.
Publicado: (2022)

Differential sensitivity to detect prosocial effects of 3,4‐methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice
por: Mukai, Satoko, et al.
Publicado: (2020)

Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex
por: Zimmermann, Josua, et al.
Publicado: (2023)

Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage
por: Bavato, F., et al.
Publicado: (2022)

Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol)
por: Lansbergen, Marieke M., et al.
Publicado: (2010)

The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis
por: Tedesco, Sarah, et al.
Publicado: (2021)

Two Simulation Cases to Prepare for a Public Festival: Pediatric Methylenedioxymethamphetamine (MDMA) Ingestion and Alcohol Toxicity
por: Roben, Emily Z, et al.
Publicado: (2018)

Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity
por: Torres, Elisa, et al.
Publicado: (2011)

Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
por: Pardo-Lozano, Ricardo, et al.
Publicado: (2012)

Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[(18)F]-ADAM PET Imaging
por: Tsai, Chi-Jung, et al.
Publicado: (2022)

A High-Resolution Magic Angle Spinning NMR Study of the Enantiodiscrimination of 3,4-Methylenedioxymethamphetamine (MDMA) by an Immobilized Polysaccharide-Based Chiral Phase
por: Barreiro, Juliana C., et al.
Publicado: (2016)

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil
por: Jardim, Alvaro V., et al.
Publicado: (2020)

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens
por: Müller, Felix, et al.
Publicado: (2020)

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
por: Breeksema, Joost J, et al.
Publicado: (2022)

Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans
por: Steuer, Andrea E., et al.
Publicado: (2016)

Methylenedioxymethamphetamine-induced toxic valvulopathy
por: Sol, Bastiaan, et al.
Publicado: (2020)

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
por: Young, M B, et al.
Publicado: (2015)

Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells
por: Popova, Dina, et al.
Publicado: (2016)

Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
por: Martins, João, et al.
Publicado: (2011)

The Effects of 3,4-methylenedioxymethamphetamine on Neurogenesis in the Hippocampus of Male Rats
por: Soleimani Asl, Sara, et al.
Publicado: (2020)

Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [(123)I]-ADAM/SPECT
por: Ma, Kuo-Hsing, et al.
Publicado: (2016)

The endotoxin hypothesis of neurodegeneration
por: Brown, Guy C.
Publicado: (2019)

Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine
por: Williams, Michael T., et al.
Publicado: (2014)

Preliminary Results on the Long-Term Effects of Dextromethorphan on MDMA-Mediated Serotonergic Deficiency and Volumetric Changes in Primates Based on 4-[(18)F]-ADAM PET/MRI
por: Yeh, Skye Hsin-Hsien, et al.
Publicado: (2022)

Zingiber Officinale Alters 3,4-methylenedioxymethamphetamine-Induced Neurotoxicity in Rat Brain
por: Mehdizadeh, Mehdi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kj58bsbgcluqnpe0r52gqu79rv